(Q53671354)

English

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. (English)

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

0 references

0 references

Lílliam Flores

3

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

author name string

Fabiola Romero

1

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Joana Nicolau

2

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Roser Casamitjana

4

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Ainitze Ibarzabal

5

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Antonio Lacy

6

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Josep Vidal

7

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Surgical Endoscopy

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

26

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

8

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

2231-2239

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

https://scigraph.springernature.com/pub.10.1007/s00464-012-2166-y

0 references

Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding.

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Ghrelin in the regulation of body weight and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Repeatability of indices of insulin sensitivity and secretion from standard liquid meal tests in subjects with type 2 diabetes mellitus or normal or impaired fasting glucose

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00464-012-2166-Y

21 January 2018

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22302537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22302537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22302537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00464-012-2166-Y

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/22302537

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53671354&oldid=1788402442"